Our guest today is Geetha Manjunath, founder and CEO of NIRAMAI Health Analytix, who has won multiple awards for her work in computer science and AI applied to healthcare. In this conversation, Geetha talks about plans to take NIRAMAI’s early-stage cancer detection technology to the advanced markets, starting with the UK. She also talks about how the day isn’t far when cancer detection will be possible using smartphones. 

(00:40) Intro to The Daily Tech Conversation

(00:53) Our guest today — Dr. Geetha Manjunath, founder and CEO, NIRAMAI Health Analytix

(01:52) A snapshot of NIRAMAI’s work and early cancer detection technology

(04:50) Examples of innovations patented by Manjunath

(10:49) Expansion into the UK

(13:08) Increasing accuracy of Thermalytix, NIRAMAI’s main product

(15:15) Portability of the device

(16:33) A device that is capable of detecting cancers as early as ‘stage zero’

(17:08) Challenges overcome in making NIRAMAI’s device both accurate and affordable

(22:22) Growing operations and expanding overseas

(24:38) Business models at NIRAMAI

(27:30) Using the cloud model to offer NIRAMAI’s AI analytics to anyone in the world

(29:01) How supportive is the Indian startup ecosystem of deep science and engineering based ventures

(33:17) Cancer detection on smartphones and beyond

More on Geetha Manjunath and NIRAMAI

https://www.niramai.com/team/geetha-manjunath/

Theme music courtesy Free Music & Sounds:

https://soundcloud.com/freemusicandsounds